^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SM-164

    i
    Other names: SM-164
    Associations
    News
    Trials
    Company:
    Ascenta
    Drug class:
    IAP antagonist
    Related drugs:
    Associations
    News
    Trials